Atlas Trials

Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates Cancer

Clinical trial NCT04801186 · COMPLETED

Trial details

NCT number
NCT04801186
Sponsor
AstraZeneca
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Castration-resistant Prostates Cancer
Start date
2021-09-28
Primary completion
2022-09-30
Enrollment
1920

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.